This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LT. PHILIP C. ANDERSON; COMDR. ROBERT L. FLECK

AMA Arch Derm. 1958;77(6):720.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Fumagillin is an antibiotic isolated by Hansen and Eble, in 1949, from Aspergillus fumigatus and later found to be amebicidal. When it is used in doses of 40-60 mg. a day for 10 to 14 days to treat human amebiasis, undesirable side-effects are seen in some patients. Headache, insomnia, nausea, tenesmus, vomiting, diarrhea, and some sensory defects are reported.^1-4 The most usual dermatologic reaction is a widespread maculopapular eruption, occasionally with an urticarial component, which usually appears by the 6th to 10th day of therapy and clears within a few days after the medication is stopped.^5,6 When this reaction was severe, Radke⁵ discontinued the drug for two days and was able to resume it without incident, which led him to call it a Jarisch-Herxheimer reaction rather than a drug eruption.

The skin reaction with which this paper is concerned is a nonerythematous scaling of the . . . [Full Text PDF of this Article]

Author Affiliations
(MC), U. S. N. R.; (MC), U. S. N.

Footnotes
Submitted for publication Dec. 16, 1957.

The opinions or assertions contained herein are the private ones of the writer, and are not to be construed as official or reflecting the news of the Navy Department or the Naval Service at large.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?